Medicinalgiganten Novo Nordisk har formået at skrue op for produktionen af Wegovy og Ozempic, så der ikke længere er mangel ...
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback